This toolkit incorporates, in an updated form, the January 2011 ‘Advice on Carbapenemase Producers: Recognition, infection control and treatment’ issued jointly by Department of Health Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), and the Health Protection Agency (HPA) now part of Public Health England (PHE).
This toolkit provides practical advice for clinicians, and staff at the frontline in an acute care setting (a similar toolkit is being prepared for the non-acute care setting). It also provides some basic public health risk assessment tools and advice and information for the patient.
The advice in this toolkit is applicable to both the NHS and the Independent Sector, into which many high-risk patients are admitted from outside the UK. If the infection, prevention and control (IP&C) advice in this toolkit does not ‘fit’ your situation, IP&C teams can obtain further advice and signposting, particularly in relation to local risk assessment, through their local PHE Centre.